F10 and kidney failure: There is no need to systematically measure anti-factor Xa levels for each patient but it could be useful in some populations such as critically ill patients because possible patient-dependent factors can influence plasma anti-factor Xa activity, like decreased bioavailability because of edema, vasoconstrictive treatment or renal failure.